Researchers solve RSV mystery; Sanofi Pasteur blueprints expansion; alliance wins $4.7M

Vaccine research

Merck KGaA paid Oncothyreon $13 million for the right to manufacture Stimuvax, an experimental lung cancer vaccine. Merck already holds the commercialization rights to the vaccine. Report

The Life Sciences Discovery Fund has awarded nearly $4.7M to the Washington Vaccine Alliance for a program to help research new vaccines for E. coli, herpes and syphilis. Report

Vaccine market

Economic development officials in Lehigh County have been wooing Sanofi Pasteur, which is planning to expand its manufacturing capability in the U.S. Report

A seasonal flu outbreak in England has hit young adults particularly hard. Story

Hester launched a poultry vaccine against Coryza disease in chicken. Report

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.